Providing Enhanced Medical Support for the African American Community During the COVID-19 Pandemic
November 3, 2020
November 3, 2021
Scroll to the Bottom of this Information to Begin this Course
Jointly provided by the Postgraduate Institute for Medicine and CE Health Interactive (CEHI).
Supported by an independent educational grant provided by Merck and Company.
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™
All other health care professionals completing this course will be issued a statement of participation.
This activity is designed to meet the educational needs of healthcare providers, including primary care practitioners, specialists, infusion nurses, pharmacists, nurse practitioners, physician assistants, and patient advocacy groups address the heightened medical and educational needs of African American patients that they treat during the current COVID-19 pandemic.
This activity will cover knowledge and practice gaps as they relate to the management of the African American community during the 2019 novel coronavirus (COVID-19) pandemic.
Upon completion of this activity, participants should be better able to:
- Discuss the heightened medical and educational needs of African American patients during the COVID-19 pandemic
- Describe what is known about the risk and severity of disease for COVID-19 in African American patients
- Review recommendations for screening and managing African American patients during the COVID-19 pandemic, including comorbidities
- Explain how to best educate African American patients about the risk of COVID-19 with Comorbidities
Kenneth Alleyne, MD
Ken Alleyne, D is a board certified sports medicine orthopedic surgeon practicing in Connecticut and Manhattan. He is a clinical associate professor of orthopedics at the University of Connecticut. Dr. Alleyne is the managing partner of HartHaven Partners, a healthcare investment and consulting firm. He is also co-founder of NextLevel Health Partners, a medicaid managed care organization in the Midwest and Zing Healthcare a technology enabled Medicare Advantage Health Plan. He serves as the team physician and consultant to many local, national and international athletic organizations. Dedicated to serving his community Dr. Alleyne is Chair of the Connecticut Health Foundation. He serves on the boards of the University of Connecticut Health Center, the Hartford City Ballet, Louis Armstrong Educational Foundation and Student Achievement Through Opportunity, an organization raising resources for academic and arts enrichment for low income students. Dr Alleyne is a graduate of Williams College and completed his medical training at Wake Forest University. Residency training was undertaken at Howard University Hospital and he subsequently completed a fellowship in sports medicine, knee and shoulder surgery at Yale University as well as tissue engineering at the Harvard-MIT Division of Health Sciences and Technology.
Reginald J. Eadie, MD, MBA
Reginald J. Eadie, MD is an accomplished and innovative leader in transforming health care and patient care to meet the needs of the 21st century. Dr. Eadie is a board-certified, emergency medicine physician. He earned his Bachelor of Science degree, with magna cum laude honors, from South Carolina State University in Orangeburg, South Carolina. Following undergraduate school, he returned to Michigan to earn his medical degree from Wayne State University School of Medicine. Also, he attended the Michigan State University Broad Business School where he received his Executive MBA. Dr. Eadie’s experience as a healthcare Executive began with his appointment as Emergency Medicine Chief. Subsequent to that, he was appointed Chief Medical Officer, and then hospital CEO at 4 different Michigan Hospitals. His successes led to him being appointed as Regional Chief Operating Officer for the Detroit Medical Center. Dr. Eadie left that role to join the Trinity Health Of New England team as President and CEO in April of 2018.
Cheryl Rucker-Whitaker, MD, MPH, FACP
Cheryl Rucker-Whitaker, MD, MPH, FACP, is President & Chair of the Institute of Medicine of Chicago, and CEO of NextLevel Health. Dr. Rucker-Whitaker is a highly accomplished, leading expert in Medicaid and Medicare regulatory environment with extensive experience in population health management and diverse populations, with expertise in community-based engagement, care, and coordination, and culturally competent solutions for culturally diverse populations. Dr. Rucker-Whitaker’s extensive education includes earning a BA in Biology from Emory University, MD from Washington University School of Medicine, and MPH, Health Policy and Management, from Harvard School of Public Health. She currently holds appointments as President, Institute of Medicine Chicago Board of Governors, and Chair, Medicaid Advisory Committee.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CEHI. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures of Conflicts of Interest
The faculty members have nothing to disclose.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CEHI planners and managers have nothing to disclose
Instructions for Participation and Credit
There are no fees for participating and receiving CME credit for this enduring activity. During the period November 1, 2020, through November 1, 2021 participants must:
- Read the CME/CE information and faculty disclosures.
- Participate in the online activity.
- Submit the evaluation form.
Course Viewing Requirements
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.